Narrowband UVB therapy for vitiligo: Does the repigmentation last?

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 7, 2007, Pages 891-896

  Sitek, J C ^a   Loeb, M ^b   Ronnevig, J R ^c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b SINTEF   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Follow up; Narrow band UVB; Pigmentation disorder; Vitiligo

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PHOTOTHERAPY; PRIORITY JOURNAL; RELAPSE; SKIN PIGMENTATION; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; ULTRAVIOLET B RADIATION; VITILIGO;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RECURRENCE; SKIN PIGMENTATION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 34547121476     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.01980.x     Document Type: Article

References (26)

1. Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and Other Hypomelanoses of Hair and Skin. Plenum Press, New York, 1983.
2. Halder RM, Grimes PE, Cowan CA et al. Childhood vitiligo. J Am Acad Dermatol 1987; 16: 948-954.
3. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int J Dermatol 1992; 31: 621-623.
4. Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W. Review of the etiopathomechanism of vitiligo: A convergence theory. Exp Dermatol 1993; 2: 145-153.
5. Kumari J. Vitiligo treated with topical clobetasol propionate. Arch Dermatol 1984; 120: 631-635.
6. Kim SM, Lee HS, Hann SK. The efficacy of low-dose corticosteroids in the treatment of vitiligo. Int J Dermatol 1999; 38: 546-550.
7. Grimes PE. Psoralen photochemotherapy for vitiligo. Clin Dermatol 1997; 15: 921-926.
8. Gupta AK, Anderson TF. Psoralen photochemotherapy. J Am Acad Dermatol 1987; 17: 703-734.
9. Hadi SM, Spencer JM, Lebwohl M. The use of excimer laser for the treatment of vitiligo. Dermatol Surg 2004; 30: 983-986.
10. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47: 789-791.
11. Silverberg NB, Lin P, Travis L et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases. J Am Acad Dermatol 2004; 51: 760-766.
12. Gupta S, Kumar B. Epidermal grafting in vitiligo: Influence of age, site of lesion and type of disease on outcome. J Am Acad Dermatol 2003; 49: 99-104.
13. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with narrowband UV-B versus topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
14. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrowband (TL-01) UV-B radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
15. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
16. Natta R, Somsak T, Wisuttida T. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003; 49: 473-476.
17. Yashar SS, Gielczyk R, Scherschum L, Lim HW. Narrowband ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed 2003; 19: 164-168.
18. Hamzavi I, Jain H, McLean D et al. Parametric modelling of narrowband UVB phototherapy for vitiligo using a novel quantitative tool: The vitiligo area scoring index. Arch Dermatol 2004; 140: 677-683.
19. Kullavanijaya P, Lim H. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2004; 20: 248-251.
20. Tjioe M, Gerritsen JP, Juhlin L, van de Kerkhof PCM. Treatment of vitiligo vulgaris with narrowband UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369-372.
21. Grimes PE. White patches and bruised souls: Advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 2004; 51: S5-S7.
22. Sterenborg HJCM, van Weelden H, van der Leun JC. The dose-response relationship for tumorigenesis by UV radiation in the region 311-312 nm. J Photochem Photobiol B 1988; 2: 179-194.
23. Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M. No evidence for increased skin cancer treated with broadband or narrowband UVB phototherapy: A first retrospective study. Acta Derm Venereol 2004; 84: 370-374.
24. Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: Early follow-up data. Br J Dermatol 2005; 152: 755-757.
25. Halder RM, Battle EF, Smith EM. Cutaneous malignancies in patients treated with photochemotherapy (PUVA) for vitiligo. Arch Dermatol 1995; 131: 734-735.
26. Schallreuter KU, Tobin DJ, Panske A. Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 2002; 204: 194-201.